Corcept Therapeutics, Inc. (CORT)

87.99 +0.86 (+0.99%) USD  |  NASDAQ  |  Dec 12, 16:00
88.03 +0.04 (+0.05%) After-Hours: 20:00
More

Corcept Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for CORT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
United Therapeutics Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade